Bryant Furlow

A common side effect of cancer treatment, including radiotherapy, is diarrhea. Treatment is based on its cause and severity.

Proposed reductions in radiotherapy prompted a joint reaction from ASTRO and other cancer care organizations.

A new study suggests radiotherapy may hold clinical promise for the control of local lymph node bed recurrence of malignant melanoma.

Emerging combination radiotherapy regimens are improving overall survival; however, associated dermatologic toxicities pose unique challenges.

An increased risk of coronary artery stenosis in cancer survivors may be a long-term posttreatment effect of chest radiotherapy.

Smart phones or tablets are being used to revolutionize clinical diagnosis and patient care, but they pose a number of risks and benefits.

New research is showing that sequence and timing have significant impact on the efficacy of therapeutic regimens that include bevacizumab.

Researchers are investigating the use of genomics to achieve better cure rates with less morbidity in patients undergoing radiation treatment.

A computer modeling study introduces concerns about tungsten-alloy multileaf collimators. ONA talks to a lead author and critics of the study.

Radiotherapy, like all medical treatments, has its risks. This discussion reviews the safety issues for patients and nurses.